首页> 外文期刊>JCO clinical cancer informatics. >Optimal Donor Selection for Hematopoietic Ce Transplantation Using Bayesian Machine Learning
【24h】

Optimal Donor Selection for Hematopoietic Ce Transplantation Using Bayesian Machine Learning

机译:使用贝叶斯机器学习进行造血CE移植的最佳供体选择

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE Donor selection practices for matched unrelated donor (MUD) hematopoietic cell transplantation (HCT) vary, and the impact of optimizing donor selection in a patient-specific way using modern machine learning (ML) models has not been studied.METHODS We trained a Bayesian MLmodel in 10,318 patients who underwent MUD HCT from 1999to2014to provide patient- and donor-specific predictions of clinically severe (grade 3 or 4) acute graft-versus-host disease or death by day 180. The model was validated in 3,501 patients from 2015 to 2016 with archived records of potential donors at search. Donor selection optimizing predicted outcomes was implemented over either an unlimited donor pool or the donors in the search archives. Posterior mean differences in outcomes from optimal donor selection versus actual practice were summarized per patient and across the population with 95% intervals.RESULTS Event rates were 33% (training) and 37% (validation). Among donor features, only age affected outcomes, with the effect consistent regardless of patient features. The median (interquartile range) difference in age between the youngest donor at search and the selected donor was 6 (1-10) years, whereas the number of donors per patient younger than the selected donor was 6 (1-36). Fourteen percent of the validation data set had an approximate 5% absolute reduction in event rates from selecting the youngest donor at search versus the actual donor used, leading to an absolute population reduction of 1% (95% interval, 0 to 3).CONCLUSION We confirmed the singular importance of selecting the youngest available MUD, irrespective of patient features, identified potential for improved HCT outcomes by selecting a younger MUD, and demonstrated use of novel ML models transferable to optimize other complex treatment decisions in a patient-specific way.
机译:匹配无关供体(泥)造血细胞移植(HCT)的目的供体选择实践变化,并且尚未研究以特定于患者的方式优化供体选择的影响,使用现代机器学习(ML)模型。从1999年至2014年接受泥浆HCT的10,318例患者中,MLMODEL提供了患者和供体特异性的预测临床严重(3级或4级)急性移植物抗宿主疾病或第180天死亡。该模型在2015年的3,501例患者中得到了验证。 2016年有搜索潜在捐助者的存档记录。捐助者选择优化预测的结果是对无限供体池或搜索档案中的捐赠者实施的。每位患者和整个人群中总结了最佳供体选择与实际实践的后期均值差异,间隔为95%。结果率为33%(培训)和37%(验证)。在捐助者的特征中,只有年龄影响的结果,无论患者特征如何,效果都一致。搜索最年轻的捐助者和选定捐助者之间年龄的中位数(四分位间范围)为6(1-10)年,而比选定捐助者年轻的患者的捐助者人数为6(1-36)。验证数据集中的14%的事件率的绝对降低约为5%,从选择最年轻的供体与实际使用的供体相比,导致绝对人口减少了1%(95%间隔,0至3)。判断。我们证实了选择最年轻的泥浆,无论患者特征如何,通过选择年轻的泥浆来确定了改善HCT结果的潜力,并证明了可转移的新型ML模型以特定于患者的方式优化其他复杂的治疗决策,从而确定了改善HCT结果的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号